Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$12.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 37 most recent Form 4 transactions.
| May 26 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 551 | $80.71 | $44.5K | -1.1% | Open the original filing on SEC.gov |
| May 26 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 4,500 | $80.02 | $360.1K | -8.4% | Open the original filing on SEC.gov |
| May 26 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 3,800 | $79.39 | $301.7K | -6.7% | Open the original filing on SEC.gov |
| May 26 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 324 | $79.17 | $25.7K | -0.6% | Open the original filing on SEC.gov |
| May 26 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 3,730 | $78.36 | $292.3K | -6.1% | Open the original filing on SEC.gov |
| Apr 22 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 200 | — | — | — | Open the original filing on SEC.gov |
| Apr 22 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 100 | — | — | — | Open the original filing on SEC.gov |
| Apr 22 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 300 | $90.00 | $27K | -0.5% | Open the original filing on SEC.gov |
| Apr 22 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 200 | $43.50 | $8.7K | +0.3% | Open the original filing on SEC.gov |
| Apr 22 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 100 | $30.17 | $3K | +0.2% | Open the original filing on SEC.gov |
| Apr 15 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 1,300 | — | — | — | Open the original filing on SEC.gov |
| Apr 15 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,300 | $90.00 | $117K | -2.1% | Open the original filing on SEC.gov |
| Apr 15 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 1,300 | $43.50 | $56.6K | +2.1% | Open the original filing on SEC.gov |
| Apr 14 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 785 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 4,466 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 5,251 | $90.00 | $472.6K | -7.9% | Open the original filing on SEC.gov |
| Apr 14 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 785 | $43.50 | $34.1K | +1.2% | Open the original filing on SEC.gov |
| Apr 14 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 4,466 | $30.17 | $134.7K | +7.3% | Open the original filing on SEC.gov |
| Apr 1 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 14,640 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,100 | $86.05 | $94.7K | -1.8% | Open the original filing on SEC.gov |
| Apr 1 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 13,540 | $85.41 | $1.2M | -17.8% | Open the original filing on SEC.gov |
| Apr 1 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 14,640 | $29.64 | $433.9K | +23.9% | Open the original filing on SEC.gov |
| Mar 31 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 7,600 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 7,600 | $85.38 | $648.9K | -11.1% | Open the original filing on SEC.gov |
| Mar 31 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 7,600 | $29.64 | $225.3K | +12.4% | Open the original filing on SEC.gov |
| Mar 25 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 24,727 | — | — | — | Open the original filing on SEC.gov |
| Mar 25 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 24,727 | $80.26 | $2M | -28.8% | Open the original filing on SEC.gov |
| Mar 25 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 24,727 | $29.64 | $732.9K | +40.4% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | MEXER◷◆ | 84,400 | — | — | — | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 1,200 | $80.05 | $96.1K | -1.9% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 6,105 | $79.87 | $487.6K | -8.9% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 8,214 | $78.40 | $644K | -10.7% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 52,975 | $77.21 | $4.1M | -40.8% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | SSELL◷ | 22,756 | $76.73 | $1.7M | -14.9% | Open the original filing on SEC.gov |
| Mar 23 | KYMR | Kymera Therapeutics, Inc. | MEXER◷ | 84,400 | $29.64 | $2.5M | +124.0% | Open the original filing on SEC.gov |